CPT-EIA assays for the detection of vancomycin resistant vanA and vanB genes in enterococci

Diagnostic Microbiology and Infectious Disease

Volumn 37, Issue 1, 2000, Pages 45-50

  Modrusan, Zora ^a   Marlowe, Cherith ^b   Wheeler, Donald ^b   Pirseyedi, Mona ^b   Bryan, Robert N ^b  

^a Experimental Station   (United States)

^b ID Biomedical Corporation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DNA PROBE; ENTEROCOCCUS; ENZYME IMMUNOASSAY; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARBON-OXYGEN LIGASES; CULTURE MEDIA; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENES, BACTERIAL; HUMANS; IMMUNOENZYME TECHNIQUES; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0034104052     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(99)00149-2     Document Type: Article

References (25)

1. Beggs M.L., Cave M.D., Cloney L., Marlowe C., Duck P., Eisenach K.D. Characterization of Mycobacterium tuberculosis complex direct repeat sequence for use in cycling probe reaction. J Clin Microbiol. 34:1996;2985-2989.
2. Bekkaoui F., McNevin J., Leung C.H., Peterson G.J., Patel A., Bhatt R.S., Bryan R.N. Rapid detection of the mecA gene in methicillin resistant staphylococci using a colorimetric cycling probe technology. Diagn Microbiol Infect Dis. 34:1999;83-90.
3. Bhairi, S. M. (1997). Detergents. In A guide to the properties and uses of detergents in biology and biochemistry (pp. 4-19). San Diego: Calbiochem-Novabiochem Corporation.
4. Clark N.C., Teixeira L., Facklam R., Tenover F.C. Detection and differentiation of vanC-1, vanC-2, and vanC-3 glycopeptide resistance in enterococci. J Clin Microbiol. 36:1998;2294-2297.
5. Cloney L., Marlowe C., Wong A., Chow R., Bryan R.N. Rapid detection of mecA in methicillin resistant Staphylococcus aureus using cycling probe technology. Mol Cell Probes. 13:1999;191-197.
6. Duck P., Alvarado-Urbina G., Burdick B., Collier B. Probe amplifier system based on chimeric cycling oligonucleotides. BioTechniques. 9:1990;142-147.
7. Dutka-Malen S., Evers S., Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol. 33:1995;24-27.
8. Dutka-Malen S., Leclercq R., Coutant V., Duval J., Courvalin P. Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria. Antimicrob Agents Chemother. 34:1990;1875-1879.
9. Endtz H.P., van den Braak N., van Belkum A., Goessens W.H., Kreft D., Stroebel A.B., Verbrugh H.A. Comparison of eight methods to detect vancomycin resistance in enterococci. J Clin Microbiol. 36:1998;592-594.
10. Hayden M.K., Trenholme G.M., Schultz J.E., Sahm D.F. In vivo. development of teicoplanin resistance in a VanB Enterococcus faecium isolate. J Infect Dis. 167:1993;1224-1227.
11. Jett B., Free L., Sahm D.F. Factors influencing the Vitek gram-positive susceptibility system's detection of vanB-encoded vancomycin resistance among enterococci. J Clin Microbiol. 34:1996;701-706.
12. Kohner P.C., Patel R., Uhl J.R., Garin K.M., Hopkins M.K., Wegener L.T., Cockerill F.R. Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated Vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin. J Clin Microbiol. 35:1997;3258-3263.
13. Landman D., Quale J.M. Management of infections due to resistant enterococci a review of therapeutic options . J Antimicrob Chem. 40:1997;161-170.
14. Leclercq R., Courvalin P. Resistance to glycopeptides in enterococci. Clin Infect Dis. 24:1997;545-556.
15. Leclercq R., Derlot E., Duval J., Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 319:1988;157-161.
16. Miele A., Bandera M., Goldstein B.P. Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates. Antimicrob Agents Chemother. 39:1995;1772-1778.
17. Modrusan Z., Bekkaoui F., Duck P. Spermine-mediated improvement of cycling probe reaction. Mol Cell Probes. 12:1998;107-116.
18. Modrusan Z., Marlowe C., Wheeler D., Pirseyedi M., Bryan R.N. Detection of vancomycin resistant genes vanA and vanB by cycling probe technology. Mol Cell Probes. 13:1999;223-231.
19. Moellering R.C. Vancomycin-resistant enterococci. Clin Infect Dis. 26:1998;1196-1199.
20. Murray B.E. Vancomycin-resistant enterococci. Am J Med. 102:1997;284-293.
21. Patel R., Uhl J.R., Kohner P., Hopkins M.K., Cockerill F.R. Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci. J Clin Microbiol. 35:1997;703-707.
22. Quintiliani R. Jr, Evers S., Courvalin P. The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci. J Infect Dis. 167:1993;1220-1223.
23. Tenover, F. C., Swenson, J. M., O'Hara, C. M., & Stocker, S. A. (1995). Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci. J Clin Microbiol 33, 1524-1527.
24. Tenover F.C., Tokars J., Swenson J., Paul S., Spitalny K., Jarvis W. Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci. J Clin Microbiol. 31:1993;1695-1699.
25. Toye B., Shymanski J., Bobrowska M., Woods W., Ramotar K. Clinical and epidemiologic significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype). J Clin Microbiol. 35:1997;3166-3170.